Description: G Medical Innovations Holdings Ltd. is an early commercial stage healthcare company engaged in the development of next generation mHealth and telemedicine solutions and monitoring service platforms. The Company’s solutions and services can empower consumers, patients and providers to better monitor, manage and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (or CVD), pulmonary disease and diabetes. The Company’s current product lines consist of its Prizma medical device (or Prizma), a clinical grade device that can transform almost any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators; its Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography (or ECG) data continuously, including its QT Syndrome Prolongation Detection Capabilities Patch. In addition, the Company is developing its Wireless Vital Signs Monitoring System (or VSMS), which is expected to provide full, continuous and real time monitoring of a wide range of vital signs and biometrics. Its monitoring services include provision of Independent Diagnostic Testing Facility (or IDTF) monitoring services and private monitoring services.
Home Page: gmedinnovations.com
GMVD Technical Analysis
5 Oppenheimer Street
Rehovot,
7670105
Israel
Phone:
972 8 958 4777
Officers
| Name | Title |
|---|---|
| Dr. Yacov Geva | Pres, CEO, MD & Exec. Director |
| Mr. Igor Bluvstein | Chief Financial Officer |
| Mr. Benny Tal | VP of R&D and CTO |
| Mr. Oded Shahar | Sr. Investment Banker and Sr. VP of Merger & Acquisition |
| Ms. Dror Nuriel-Roth | Exec. VP of US Operations |
| Mr. Kobi Ben Efraim | Controller |
| Mr. Brett Tucker | Company Sec. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 6.0906 |
| Price-to-Sales TTM: | 0.4842 |
| IPO Date: | 2018-01-31 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |